MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Calithera Biosciences Company Profile (NASDAQ:CALA)

Consensus Ratings for Calithera Biosciences (NASDAQ:CALA) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.00 (136.69% upside)

Analysts' Ratings History for Calithera Biosciences (NASDAQ:CALA)
Show:
DateFirmActionRatingPrice TargetActions
5/12/2016Wells FargoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$20.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$20.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015Leerink SwannLower Price TargetOutperform$19.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Citigroup Inc.Initiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha